Market Trends Merck cancer drug Welireg approved in EU (MRK:NYSE)By admin8996erT0allFebruary 18, 2025 Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a…
Market Trends Merck gets priority review for Welireg for PPGL (MRK:NYSE)By admin8996erT0allJanuary 27, 2025 Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…
